Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01559571 · ClinicalTrials.gov registry record
Registry for Severe ROP and Treatment on Visual Outcomes
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 324
- Enrollment target
NCT01559571: Completed study, sponsored by Pediatrix.
NCT01559571 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 324 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01559571 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 324 participants
- Enrollment target
Study Summary
The purpose of this study is to determine what factors influence the visual outcomes of infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2012-05 |
| Est. Completion | 2020-05-15 |
What the finished NCT01559571 record still lists
NCT01559571 is an observational study that tracks outcomes without assigning an intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01559571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01559571 about?
NCT01559571 is a clinical study titled "Registry for Severe ROP and Treatment on Visual Outcomes". The purpose of this study is to determine what factors influence the visual outcomes of infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.
What is the current status of trial NCT01559571?
This trial is currently completed. The enrollment target is 324 participants. The study started on 2012-05. Estimated completion is 2020-05-15.
Who is sponsoring clinical trial NCT01559571?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia